Marketing and Privacy Issues: An Analysis of the MMA and Proposed Regulations
This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.
Issue Brief (.pdf)
also of interest
- Medicare at a Glance
- One Year into Duals Demo Enrollment: Early Expectations Meet Reality
- Financial and Administrative Alignment Demonstrations for Dual Eligible Beneficiaries Compared: States with Memoranda of Understanding Approved by CMS
- Financial Alignment Demonstrations for Dual Eligible Beneficiaries: A Look at CMS’s Evaluation Plan